We are live on
!
Find out more
E
Ergoteles Portfolio holdings
AUM
$68.2M
1-Year Est. Return
36.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.32%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
-$123M
(-4.3%)
Cap. Flow
-$215M
Cap. Flow
% of AUM
-7.9%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,200
New
704
Increased
294
Reduced
353
Closed
800
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$85.8M |
| 2 |
Steel Dynamics
STLD
|
+$50.2M |
| 3 |
McKesson
MCK
|
+$43.7M |
| 4 |
STOR
STORE Capital Corporation
STOR
|
+$38.2M |
| 5 |
Arch Capital
ACGL
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$149M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$147M |
| 3 |
NLSN
Nielsen Holdings plc
NLSN
|
+$44.3M |
| 4 |
CoStar Group
CSGP
|
+$44.2M |
| 5 |
Chevron
CVX
|
+$43.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.28% |
| 2 | Healthcare | 12.35% |
| 3 | Industrials | 12.24% |
| 4 | Technology | 10.34% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Compañía de Minas Buenaventura
BVN
$8.06B
| $149K | 0.01% |
+20,053
| New | +$149K |
|
1152
Voyager Therapeutics
VYGR
$187M
| $149K | 0.01% |
+24,379
| New | +$139K |
|
1153
AC Immune
ACIU
$234M
| $148K | 0.01% |
+72,632
| New | +$187K |
|
1154
ING
ING
$95.7B
| $147K | 0.01% |
+12,119
| New | +$132K |
|
|
VGR
1155
DELISTED
Vector Group Ltd.
VGR
| $143K | 0.01% |
12,090
-13,194
| -52% | -$139K |
|
1156
Magnite
MGNI
$2.73B
| $143K | 0.01% |
13,527
-12,741
| -49% | -$116K |
|
|
CIZN
1157
DELISTED
Citizens Holding Co.
CIZN
| $142K | 0.01% |
10,370
-803
| -7% | -$11.4K |
|
1158
Coty
COTY
$2.39B
| $142K | 0.01% |
+16,593
| New | +$122K |
|
|
MAGN
1159
Magnera Corp
MAGN
$490M
| $142K | 0.01% |
3,920
-22,242
| -85% | -$908K |
|
|
GENQ
1160
DELISTED
Genesis Unicorn Capital Corp. Class A Common Stock
GENQ
| $142K | 0.01% |
+13,942
| New | +$140K |
|
1161
Ovid Therapeutics
OVID
$439M
| $141K | 0.01% |
+75,923
| New | +$129K |
|
1162
Groupon
GRPN
$1.05B
| $141K | 0.01% |
+16,405
| New | +$127K |
|
1163
EyePoint Inc
EYPT
$1.04B
| $141K | 0.01% |
+40,203
| New | +$177K |
|
|
AIFU
1164
AIFU Inc
AIFU
$205M
| $140K | 0.01% |
47
-36
| -43% | -$83.5K |
|
|
DO
1165
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $138K | 0.01% |
+13,256
| New | +$121K |
|
|
MSAC
1166
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $137K | 0.01% |
13,580
| – | – |
|
|
FLNT
1167
Fluent
FLNT
$99.9M
| $137K | 0.01% |
20,880
-8,821
| -30% | -$64.8K |
|
|
OMIC
1168
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $136K | 0.01% |
+2,263
| New | +$152K |
|
1169
Harvard Bioscience
HBIO
$27M
| $135K | 0.01% |
4,884
-9,871
| -67% | -$243K |
|
|
DENN
1170
DELISTED
Denny's
DENN
| $135K | 0.01% |
14,655
-639
| -4% | -$6.92K |
|
1171
Astronics
ATRO
$3.47B
| $134K | ﹤0.01% |
+15,654
| New | +$116K |
|
|
PGRE
1172
DELISTED
Paramount Group
PGRE
| $134K | ﹤0.01% |
+22,475
| New | +$140K |
|
1173
Codexis
CDXS
$141M
| $133K | ﹤0.01% |
28,593
+9,156
| +47% | +$50.2K |
|
1174
PureCycle Technologies
PCT
$1.2B
| $132K | ﹤0.01% |
+19,568
| New | +$141K |
|
1175
INNOVATE Corp
VATE
$116M
| $132K | ﹤0.01% |
7,044
-12,976
| -65% | -$137K |
|
Similar funds
ROC
IVMX
AM
JCG
JAMONY
FA
VCM
MCMI
Ergoteles's Q4 2022 Portfolio in Review
As of Q4 2022, Ergoteles held 2,200 positions worth $2.72B, down 4.3% from $2.85B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ergoteles withdrew a net $215M in Q4 2022, closing 800 positions and reducing 353 holdings. Its most notable exit was Citrix Systems Inc, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ergoteles opened a new position in McKesson worth $43.9M.
- Ergoteles's largest Q4 2022 buy was McKesson: 117,079 shares worth $43.9M.
- Ergoteles added most to iShares Biotechnology ETF in Q4 2022, an estimated $85.8M increase.
- Ergoteles's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $41.8M.
- Ergoteles fully exited Citrix Systems Inc in Q4 2022, selling an estimated $149M.
- Ergoteles's ten largest holdings make up 17% of its $2.72B portfolio in Q4 2022.
- Ergoteles opened 704 new positions and closed 800 in Q4 2022.
- Ergoteles's portfolio value fell 4.3% quarter-over-quarter to $2.72B.
Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.